» Articles » PMID: 29113410

A Risk Prediction System of Postoperative Hemorrhage Following Laparoscopy-assisted Radical Gastrectomy with D2 Lymphadenectomy for Primary Gastric Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Nov 9
PMID 29113410
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate risk factors of postoperative hemorrhage (PH) following laparoscopy-assisted radical gastrectomy (LARG) with D2 lymphadenectomy for primary gastric cancer (PGC) and to use those risk factors to develop a scoring system for risk assessment.

Materials And Methods: A total of 1789 PGC patients were enrolled in our study. We analyzed the risk factors of PH and constructed a scoring system using 75% of the cases as the experimental group and 25% of the cases as a verification group to demonstrate the effectiveness.

Results: Among these 1789 patients, 46 (2.6%) developed PH. Univariate and multivariate analysis in the experimental group indicated that having more than 41 lymph node excisions, combined organ resection, stage III tumor and postoperative digestive fistula were independent risk factors of PH. According to the independent risk factors, we constructed a scoring system to separate patients into low-risk (0-2 points) and high-risk (≥ 3 points) groups. The area under the ROC curve for this scoring system was 0.748. In the verification group, the risk of PH predicted by the scoring system was not significantly different from the actual incidence observed.

Conclusions: This scoring system could simply and effectively predict the occurrence of PH following LARG with D2 lymphadenectomy for PGC. The predictive system will help surgeons evaluate risk and select risk-adapted interventions to improve surgical safety.

Citing Articles

Postoperative major bleeding risk in patients using oral antiplatelets and/or anticoagulants after laparoscopic gastric cancer surgery.

Im C, Park Y, Min S, Kang S, Lee S, Lee E Ann Surg Treat Res. 2023; 104(2):80-89.

PMID: 36816732 PMC: 9929431. DOI: 10.4174/astr.2023.104.2.80.


Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection.

Gao J, Ren W, Xiao C, Wang L, Huang Q, Zhang Z BMC Cancer. 2019; 19(1):1069.

PMID: 31703635 PMC: 6839152. DOI: 10.1186/s12885-019-6222-z.


Compliance to D2 lymphadenectomy in laparoscopic gastrectomy.

Eshuis W, van Berge Henegouwen M, Draaisma W, Gisbertz S Updates Surg. 2018; 70(2):197-205.

PMID: 29926307 PMC: 6060987. DOI: 10.1007/s13304-018-0553-1.

References
1.
Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M . Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004; 22(14):2767-73. DOI: 10.1200/JCO.2004.10.184. View

2.
Yekebas E, Wolfram L, Cataldegirmen G, Habermann C, Bogoevski D, Koenig A . Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections. Ann Surg. 2007; 246(2):269-80. PMC: 1933568. DOI: 10.1097/01.sla.0000262953.77735.db. View

3.
. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016; 20(1):1-19. PMC: 5215069. DOI: 10.1007/s10120-016-0622-4. View

4.
Wohrer S, Raderer M, Hejna M . Palliative chemotherapy for advanced gastric cancer. Ann Oncol. 2004; 15(11):1585-95. DOI: 10.1093/annonc/mdh422. View

5.
Yasunaga H, Horiguchi H, Kuwabara K, Matsuda S, Fushimi K, Hashimoto H . Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg. 2012; 257(4):640-6. DOI: 10.1097/SLA.0b013e31826fd541. View